LifeSpan BioSciences, Inc. announces the acquisition of Nordic MUbio and Exalpha Biologicals

Seattle, Washington State, USA– June 2019 – LifeSpan BioSciences (LSBio), a leading provider of antibodies and life science research reagents is pleased to announce its acquisition of Nordic MUbio. The acquisition of Nordic MUbio further expands the LSBio product offering and strengthens the LSBio position as one of the fastest growing companies in the research reagent market.  Read more